Keiji Nishijima
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Use of diabetes medications in adults with T2D and CVD in Japan: secondary analysis of the CAPTURE study.
Journal: Diabetology international
Published: November 25, 2022
Cardiovascular disease prevalence in adults with type 2 diabetes in Japan: results from the Japanese centers in the CAPTURE study.
Journal: Diabetology international
Published: March 08, 2022
A randomized trial to investigate the efficacy and safety of once-daily liraglutide 1.8 mg in Japanese adults with type 2 diabetes exhibiting an inadequate response to liraglutide 0.9 mg.
Journal: Journal of diabetes investigation
Published: November 09, 2021
Long-term efficacy and safety of two doses of Norditropin® (somatropin) in Noonan syndrome: a 4-year randomized, double-blind, multicenter trial in Japanese patients.
Journal: Endocrine journal
Published: April 10, 2020
Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial.
Journal: The lancet. Diabetes & endocrinology
Published: December 10, 2019
Efficacy and safety of two doses of Norditropin® (somatropin) in short stature due to Noonan syndrome: a 2-year randomized, double-blind, multicenter trial in Japanese patients.
Journal: Endocrine journal
Published: November 08, 2017
Efficacy and safety of adding liraglutide to existing insulin regimens in Japanese patients with type 2 diabetes mellitus: A post-hoc analysis of a phase 3 randomized clinical trial.
Journal: Journal of diabetes investigation
Published: August 22, 2017
Safety and efficacy of the combination of the glucagon-like peptide-1 receptor agonist liraglutide with an oral antidiabetic drug in Japanese patients with type 2 diabetes: Post-hoc analysis of a randomized, 52-week, open-label, parallel-group trial.
Journal: Journal of diabetes investigation
Published: May 08, 2017
Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36-week, randomized, double-blind, parallel-group trial.
Journal: Journal of diabetes investigation
Published: August 10, 2015
Liraglutide is effective and well tolerated in combination with an oral antidiabetic drug in Japanese patients with type 2 diabetes: A randomized, 52-week, open-label, parallel-group trial.
Journal: Journal of diabetes investigation
Published: December 15, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026